ArticleJournal of molecular histology2026

Study on the synergistic efficacy and mechanism of CD24 silencing combined with trastuzumab in HER2-positive breast cancer.

Yi Lu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.